No Data
Danaher (DHR) Gears Up to Post Q2 Earnings: What to Expect
However, decreased demand in the bioprocessing business is likely to have hurt the Biotechnology segment’s revenues.
Express News | Danaher Corp : JP Morgan Cuts Target Price to $295 From $300
Express News | Danaher Announced The Launch Of Two New Clinical Laboratory Improvement Amendments And College Of American Pathologists-certified Labs Intended To Accelerate The Development Of Companion Diagnostics And Complementary Diagnostics
Danaher Announces Two New Centers of Innovation in Diagnostics to Transform Precision Medicine Development
DH Diagnostics LLC Centers aim to accelerate drug development by speeding and streamlining development and commercialization of companion diagnostics.Clinical Laboratory Improvement Amendments (CLIA)
(DHR) - Analyzing Danaher's Short Interest
Danaher's (NYSE:DHR) short percent of float has risen 11.11% since its last report. The company recently reported that it has 8.61 million shares sold short, which is 1.3% of all regular shares that
Danaher (DHR) Upgraded to Buy: Here's What You Should Know